Anika Therapeutics (ANIK)
|
10.70
+0.02 (+0.19%)
|
|
|
|
ANIK additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ANIK Profile
•
Exchange
NASDAQ
•
Held by these Mutual Funds
•
Executives
Dr. Charles H. Sherwood Ph.D.
Chief Exec. Officer
Pres and Director
Mr. Kevin W. Quinlan
Chief Financial Officer
Principal Accounting Officer Treasurer and Sec.
Mr. Frank J. Luppino
Chief Operating Officer
Dr. Jing-Wen Kuo Ph.D. r>Chief Scientific Officer
Mr. Edward Gaj Jr. Ph
VP of Bus. Devel.
Chief Exec. Officer
Pres and Director
Mr. Kevin W. Quinlan
Chief Financial Officer
Principal Accounting Officer Treasurer and Sec.
Mr. Frank J. Luppino
Chief Operating Officer
Dr. Jing-Wen Kuo Ph.D. r>Chief Scientific Officer
Mr. Edward Gaj Jr. Ph
VP of Bus. Devel.
•
Employee Count
129
Special Offers
Competitors
ANIK earnings
Date
Actual
Expected
Prev Yr Qtr
10/30/2012
0.12
0.17
0.22
8/1/2012
0.26
0.16
5/3/2012
0.14
0.17
